data from von-hippel-lindau clinical trial shows promise for hif-2a inhibitor
Published 4 years ago • 174 plays • Length 4:53Download video MP4
Download video MP3
Similar videos
-
2:44
novel von hippel-lindau syndrome therapies inhibiting hif-2α
-
3:28
mk-6482 to treat renal cell carcinoma in von hippel-lindau disease patients
-
58:42
"von hippel-lindau disease", a scientific lecture by nobel laureate william g. kaelin
-
1:48
dr. jonasch on next steps with mk-6482 in von hippel-lindau disease–associated rcc
-
9:35
litespark-004: 36 month follow-up of belzutifan in von hippel-lindau syndrome
-
38:10
von hippel-lindau disease: neurologic and otologic manifestations - dr mehta
-
4:39
clear cell rcc: vhl/hif pathway
-
2:48
oral hif-2 α inhibitor mk-6482 in patients with advanced clear cell renal cell carcinoma
-
5:12
von hippel lindau disease || kidney || renal
-
0:55
what is the connection between von hippel-lindau syndrome and kidney cancer?
-
6:09
belzutifan for vhl disease-associated renal cell carcinoma
-
1:19
von hippel lindau disease
-
2:21
phase ii study of the oral hif-2α inhibitor mk-6482
-
0:58
diagnostics: htlv blood screening confirmation [mp biomedicals asia pacific]
-
4:32
pazopanib for patients with von hippel-lindau (vhl) disease
-
0:31
listen to your heart - fountain valley regional hospital
-
8:33
medpix video - phakomatoses: von hippel-lindau syndrome
-
6:10
the von hippel-lindau (vhl) program at northwestern memorial hospital
-
3:01
what is von hippel-lindau disease?